NEWS | Vendors
» Hill-Rom will pay $183 million to acquire
Specialty drug price hikes
Liko, a Sweden-based company that makes
lifts and slings that are used to move patients.
The acquisition is part of an ongoing growth
strategy at Hill-Rom, according to company
far outstrip inflation: AARP
BY JOHN O’CONNOR Specialty drugs are currently
The cost for specialty drugs that among the most expensive
» Pellerin Milnor announced that it has are used by seniors to treat com- drugs on the market, with prices
invested in the Oracle E-Business Suite. The plex conditions rose three times that can range from $5,000 to
laundry equipment manufacturer plans to faster than the overall rate of more than $300,000 per year.
completely replace its current enterprise inflation last year, according to a “Specialty drug makers contin-
resource planning system with Oracle by next new AARP study. ue to raise the costs of drugs that
spring. Last year, the wholesale price have already been developed
providers paid for specialty drugs and tested,” Rother said.
» GE Healthcare has introduced an appli- rose 8.7%; the price of non-spe- The list includes products
cation that integrates data from patient moni- cialty, branded drugs rose 7.4%; The AARP report takes a look at what from well-known firms such as
toring devices from any vendor to its and the price of generic drugs fell pharmaceutical companies are charg- Amgen, Genentech, Pfizer and
Centricity Enterprise electronic health by 9.6%, according to investiga- ing for specialty drugs. Ortho Biotech, a J&J subsidiary.
records software. The application will work tors. AARP’s survey covers 144 Drug makers defend the high
with bedside devices in any monitored envi- brand-name and generic medi- comfort and hope to those indi- prices by pointing to high re-
ronment, according to the firm. cines that are often used by peo- viduals and their families,” he search costs, small patient popu-
ple who are enrolled in the added. “But even the most lations and the complexities of
Medicare program. miraculous drug is useless if a manufacturing biotech drugs.
» The American Seniors Housing The relatively substantial cost person can’t afford to take it.’’ However, Pharmaceutical Re-
Association has released a 15-page report hike illustrates the need for law- The prices, based on manufac- search and Manufacturers of
that examines the growing use of brain fit- makers to pass seniors-friendly turers’ charges to providers or America Senior Vice President
ness programs in the eldercare field. The legislation that would get cheap- pharmacies, have been on a Ken Johnson took issue with the
study was prepared by SharpBrains. er generics to the market more steep incline since Medicare report and some of its findings.
quickly and allow meds to be began drug coverage in 2006, He